Selected research
Market Analysis & Forecast
Global Cystic Fibrosis Drugs Market Analysis and Forecast 2026-2032
Market perspective
The global Cystic Fibrosis Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cystic Fibrosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cystic Fibrosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cystic Fibrosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cystic Fibrosis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Cystic Fibrosis Drugs include Abbott, Johnson & Johnson, Novartis, Vertex Pharmaceuticals, Venus Remedies, United Medical, PTC Therapeutics, Proteostasis Therapeutics and Pharmaxis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Cystic Fibrosis Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cystic Fibrosis Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Cystic Fibrosis Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cystic Fibrosis Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cystic Fibrosis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cystic Fibrosis Drugs sales, projected growth trends, production technology, application and end-user industry.
Cystic Fibrosis Drugs Segment by Company
Abbott
Johnson & Johnson
Novartis
Vertex Pharmaceuticals
Venus Remedies
United Medical
PTC Therapeutics
Proteostasis Therapeutics
Pharmaxis
PharmaSwiss
Novo Nordisk
Neovii Biotech
Merck Sharp & Dohme
Insmed
Gilead Sciences
Genzyme
F. Hoffmann-La Roche
Corbus Pharmaceuticals
Chiesi Farmaceutici
Boehringer Ingelheim
Arcturus Therapeutics
Anthera Pharmaceuticals
Actavis
Cystic Fibrosis Drugs Segment by Type
Oral Cystic Fibrosis Drugs
Injection Cystic Fibrosis Drugs
Cystic Fibrosis Drugs Segment by Application
Hospitals
Clinics
Other
Cystic Fibrosis Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cystic Fibrosis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cystic Fibrosis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cystic Fibrosis Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cystic Fibrosis Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cystic Fibrosis Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cystic Fibrosis Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Cystic Fibrosis Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Table 2. Oral Cystic Fibrosis Drugs Major Manufacturers
Table 3. Injection Cystic Fibrosis Drugs Major Manufacturers
Table 4. Global Cystic Fibrosis Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Table 5. Hospitals Major Manufacturers
Table 6. Clinics Major Manufacturers
Table 7. Other Major Manufacturers
Table 8. Cystic Fibrosis Drugs Industry Trends
Table 9. Cystic Fibrosis Drugs Industry Drivers
Table 10. Cystic Fibrosis Drugs Industry Opportunities and Challenges
Table 11. Cystic Fibrosis Drugs Industry Restraints
Table 12. Global Cystic Fibrosis Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 13. Global Cystic Fibrosis Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 14. Global Cystic Fibrosis Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 15. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2021-2026)
Table 16. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2027-2032)
Table 17. Global Cystic Fibrosis Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units)
Table 18. Global Cystic Fibrosis Drugs Sales by Region (2021-2026) & (K Units)
Table 19. Global Cystic Fibrosis Drugs Sales by Region (2027-2032) & (K Units)
Table 20. Global Cystic Fibrosis Drugs Sales Market Share by Region (2021-2026)
Table 21. Global Cystic Fibrosis Drugs Sales Market Share by Region (2027-2032)
Table 22. Global Cystic Fibrosis Drugs Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 23. Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2021-2026)
Table 24. Global Cystic Fibrosis Drugs Sales by Manufacturers (US$ Million) & (2021-2026)
Table 25. Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2021-2026)
Table 26. Global Cystic Fibrosis Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026)
Table 27. Global Cystic Fibrosis Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 28. Global Cystic Fibrosis Drugs Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Cystic Fibrosis Drugs Manufacturers, Product Type & Application
Table 30. Global Cystic Fibrosis Drugs Manufacturers' Establishment Date
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Cystic Fibrosis Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 33. Global Cystic Fibrosis Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Cystic Fibrosis Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 35. Global Cystic Fibrosis Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 36. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2021-2026)
Table 37. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2027-2032)
Table 38. Global Cystic Fibrosis Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units)
Table 39. Global Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 40. Global Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 41. Global Cystic Fibrosis Drugs Sales Market Share by Type (2021-2026)
Table 42. Global Cystic Fibrosis Drugs Sales Market Share by Type (2027-2032)
Table 43. Global Cystic Fibrosis Drugs Price by Type (2021-2026) & (US$/Unit)
Table 44. Global Cystic Fibrosis Drugs Price by Type (2027-2032) & (US$/Unit)
Table 45. Global Cystic Fibrosis Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 46. Global Cystic Fibrosis Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 47. Global Cystic Fibrosis Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 48. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2021-2026)
Table 49. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2027-2032)
Table 50. Global Cystic Fibrosis Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units)
Table 51. Global Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Global Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 53. Global Cystic Fibrosis Drugs Sales Market Share by Application (2021-2026)
Table 54. Global Cystic Fibrosis Drugs Sales Market Share by Application (2027-2032)
Table 55. Global Cystic Fibrosis Drugs Price by Application (2021-2026) & (US$/Unit)
Table 56. Global Cystic Fibrosis Drugs Price by Application (2027-2032) & (US$/Unit)
Table 57. Abbott Company Information
Table 58. Abbott Business Overview
Table 59. Abbott Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 60. Abbott Cystic Fibrosis Drugs Product Portfolio
Table 61. Abbott Recent Development
Table 62. Johnson & Johnson Company Information
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 65. Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
Table 66. Johnson & Johnson Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Business Overview
Table 69. Novartis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 70. Novartis Cystic Fibrosis Drugs Product Portfolio
Table 71. Novartis Recent Development
Table 72. Vertex Pharmaceuticals Company Information
Table 73. Vertex Pharmaceuticals Business Overview
Table 74. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 76. Vertex Pharmaceuticals Recent Development
Table 77. Venus Remedies Company Information
Table 78. Venus Remedies Business Overview
Table 79. Venus Remedies Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Venus Remedies Cystic Fibrosis Drugs Product Portfolio
Table 81. Venus Remedies Recent Development
Table 82. United Medical Company Information
Table 83. United Medical Business Overview
Table 84. United Medical Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. United Medical Cystic Fibrosis Drugs Product Portfolio
Table 86. United Medical Recent Development
Table 87. PTC Therapeutics Company Information
Table 88. PTC Therapeutics Business Overview
Table 89. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 91. PTC Therapeutics Recent Development
Table 92. Proteostasis Therapeutics Company Information
Table 93. Proteostasis Therapeutics Business Overview
Table 94. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 96. Proteostasis Therapeutics Recent Development
Table 97. Pharmaxis Company Information
Table 98. Pharmaxis Business Overview
Table 99. Pharmaxis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Pharmaxis Cystic Fibrosis Drugs Product Portfolio
Table 101. Pharmaxis Recent Development
Table 102. PharmaSwiss Company Information
Table 103. PharmaSwiss Business Overview
Table 104. PharmaSwiss Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
Table 106. PharmaSwiss Recent Development
Table 107. Novo Nordisk Company Information
Table 108. Novo Nordisk Business Overview
Table 109. Novo Nordisk Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
Table 111. Novo Nordisk Recent Development
Table 112. Neovii Biotech Company Information
Table 113. Neovii Biotech Business Overview
Table 114. Neovii Biotech Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
Table 116. Neovii Biotech Recent Development
Table 117. Merck Sharp & Dohme Company Information
Table 118. Merck Sharp & Dohme Business Overview
Table 119. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
Table 121. Merck Sharp & Dohme Recent Development
Table 122. Insmed Company Information
Table 123. Insmed Business Overview
Table 124. Insmed Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Insmed Cystic Fibrosis Drugs Product Portfolio
Table 126. Insmed Recent Development
Table 127. Gilead Sciences Company Information
Table 128. Gilead Sciences Business Overview
Table 129. Gilead Sciences Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
Table 131. Gilead Sciences Recent Development
Table 132. Genzyme Company Information
Table 133. Genzyme Business Overview
Table 134. Genzyme Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Genzyme Cystic Fibrosis Drugs Product Portfolio
Table 136. Genzyme Recent Development
Table 137. F. Hoffmann-La Roche Company Information
Table 138. F. Hoffmann-La Roche Business Overview
Table 139. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
Table 141. F. Hoffmann-La Roche Recent Development
Table 142. Corbus Pharmaceuticals Company Information
Table 143. Corbus Pharmaceuticals Business Overview
Table 144. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 146. Corbus Pharmaceuticals Recent Development
Table 147. Chiesi Farmaceutici Company Information
Table 148. Chiesi Farmaceutici Business Overview
Table 149. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
Table 151. Chiesi Farmaceutici Recent Development
Table 152. Boehringer Ingelheim Company Information
Table 153. Boehringer Ingelheim Business Overview
Table 154. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
Table 156. Boehringer Ingelheim Recent Development
Table 157. Arcturus Therapeutics Company Information
Table 158. Arcturus Therapeutics Business Overview
Table 159. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 161. Arcturus Therapeutics Recent Development
Table 162. Anthera Pharmaceuticals Company Information
Table 163. Anthera Pharmaceuticals Business Overview
Table 164. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 166. Anthera Pharmaceuticals Recent Development
Table 167. Actavis Company Information
Table 168. Actavis Business Overview
Table 169. Actavis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Actavis Cystic Fibrosis Drugs Product Portfolio
Table 171. Actavis Recent Development
Table 172. North America Cystic Fibrosis Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 173. North America Cystic Fibrosis Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 174. North America Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 175. North America Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 176. North America Cystic Fibrosis Drugs Sales Price by Type (2021-2026) & (US$/Unit)
Table 177. North America Cystic Fibrosis Drugs Sales Price by Type (2027-2032) & (US$/Unit)
Table 178. North America Cystic Fibrosis Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 179. North America Cystic Fibrosis Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 180. North America Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 181. North America Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 182. North America Cystic Fibrosis Drugs Sales Price by Application (2021-2026) & (US$/Unit)
Table 183. North America Cystic Fibrosis Drugs Sales Price by Application (2027-2032) & (US$/Unit)
Table 184. North America Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 185. North America Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 186. North America Cystic Fibrosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 187. North America Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units)
Table 188. North America Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 189. North America Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 190. North America Cystic Fibrosis Drugs Sales Price by Country (2021-2026) & (US$/Unit)
Table 191. North America Cystic Fibrosis Drugs Sales Price by Country (2027-2032) & (US$/Unit)
Table 192. United States Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 193. Canada Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 194. Europe Cystic Fibrosis Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 195. Europe Cystic Fibrosis Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 196. Europe Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 197. Europe Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 198. Europe Cystic Fibrosis Drugs Sales Price by Type (2021-2026) & (US$/Unit)
Table 199. Europe Cystic Fibrosis Drugs Sales Price by Type (2027-2032) & (US$/Unit)
Table 200. Europe Cystic Fibrosis Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 201. Europe Cystic Fibrosis Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 202. Europe Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 203. Europe Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 204. Europe Cystic Fibrosis Drugs Sales Price by Application (2021-2026) & (US$/Unit)
Table 205. Europe Cystic Fibrosis Drugs Sales Price by Application (2027-2032) & (US$/Unit)
Table 206. Europe Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 207. Europe Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 208. Europe Cystic Fibrosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 209. Europe Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units)
Table 210. Europe Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 211. Europe Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 212. Europe Cystic Fibrosis Drugs Sales Price by Country (2021-2026) & (US$/Unit)
Table 213. Europe Cystic Fibrosis Drugs Sales Price by Country (2027-2032) & (US$/Unit)
Table 214. Germany Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 215. France Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 216. U.K. Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 217. Italy Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 218. Netherlands Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 219. Nordic Countries Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 220. China Cystic Fibrosis Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 221. China Cystic Fibrosis Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 222. China Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 223. China Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 224. China Cystic Fibrosis Drugs Sales Price by Type (2021-2026) & (US$/Unit)
Table 225. China Cystic Fibrosis Drugs Sales Price by Type (2027-2032) & (US$/Unit)
Table 226. China Cystic Fibrosis Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 227. China Cystic Fibrosis Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 228. China Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 229. China Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 230. China Cystic Fibrosis Drugs Sales Price by Application (2021-2026) & (US$/Unit)
Table 231. China Cystic Fibrosis Drugs Sales Price by Application (2027-2032) & (US$/Unit)
Table 232. Asia Cystic Fibrosis Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 233. Asia Cystic Fibrosis Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 234. Asia Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 235. Asia Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 236. Asia Cystic Fibrosis Drugs Sales Price by Type (2021-2026) & (US$/Unit)
Table 237. Asia Cystic Fibrosis Drugs Sales Price by Type (2027-2032) & (US$/Unit)
Table 238. Asia Cystic Fibrosis Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 239. Asia Cystic Fibrosis Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 240. Asia Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 241. Asia Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 242. Asia Cystic Fibrosis Drugs Sales Price by Application (2021-2026) & (US$/Unit)
Table 243. Asia Cystic Fibrosis Drugs Sales Price by Application (2027-2032) & (US$/Unit)
Table 244. Asia Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 245. Asia Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 246. Asia Cystic Fibrosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 247. Asia Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units)
Table 248. Asia Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 249. Asia Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 250. Asia Cystic Fibrosis Drugs Sales Price by Country (2021-2026) & (US$/Unit)
Table 251. Asia Cystic Fibrosis Drugs Sales Price by Country (2027-2032) & (US$/Unit)
Table 252. Japan Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 253. South Korea Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 254. India Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 255. Australia Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 256. China Taiwan Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 257. Southeast Asia Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 258. SAMEA Cystic Fibrosis Drugs Revenue by Type (2021-2026) & (US$ Million)
Table 259. SAMEA Cystic Fibrosis Drugs Revenue by Type (2027-2032) & (US$ Million)
Table 260. SAMEA Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 261. SAMEA Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 262. SAMEA Cystic Fibrosis Drugs Sales Price by Type (2021-2026) & (US$/Unit)
Table 263. SAMEA Cystic Fibrosis Drugs Sales Price by Type (2027-2032) & (US$/Unit)
Table 264. SAMEA Cystic Fibrosis Drugs Revenue by Application (2021-2026) & (US$ Million)
Table 265. SAMEA Cystic Fibrosis Drugs Revenue by Application (2027-2032) & (US$ Million)
Table 266. SAMEA Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 267. SAMEA Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 268. SAMEA Cystic Fibrosis Drugs Sales Price by Application (2021-2026) & (US$/Unit)
Table 269. SAMEA Cystic Fibrosis Drugs Sales Price by Application (2027-2032) & (US$/Unit)
Table 270. SAMEA Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 271. SAMEA Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million)
Table 272. SAMEA Cystic Fibrosis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million)
Table 273. SAMEA Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units)
Table 274. SAMEA Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 275. SAMEA Cystic Fibrosis Drugs Sales by Country (2027-2032) & (K Units)
Table 276. SAMEA Cystic Fibrosis Drugs Sales Price by Country (2021-2026) & (US$/Unit)
Table 277. SAMEA Cystic Fibrosis Drugs Sales Price by Country (2027-2032) & (US$/Unit)
Table 278. Brazil Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 279. Argentina Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 280. Chile Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 281. Colombia Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 282. Peru Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 283. Saudi Arabia Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 284. Israel Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 285. UAE Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 286. Turkey Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 287. Iran Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 288. Egypt Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Table 289. Key Raw Materials
Table 290. Raw Materials Key Suppliers
Table 291. Cystic Fibrosis Drugs Distributors List
Table 292. Cystic Fibrosis Drugs Customers List
Table 293. Research Programs/Design for This Report
Table 294. Authors List of This Report
Table 295. Secondary Sources
Table 296. Primary Sources
List of Figures
Figure 1. Cystic Fibrosis Drugs Image
Figure 2. Global Cystic Fibrosis Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Cystic Fibrosis Drugs Market Size Share 2021 VS 2025 VS 2032
Figure 4. Oral Cystic Fibrosis Drugs Image
Figure 5. Injection Cystic Fibrosis Drugs Image
Figure 6. Global Cystic Fibrosis Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Figure 7. Global Cystic Fibrosis Drugs Market Size Share 2021 VS 2025 VS 2032
Figure 8. Hospitals Image
Figure 9. Clinics Image
Figure 10. Other Image
Figure 11. Global Cystic Fibrosis Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Cystic Fibrosis Drugs Revenue (2021-2032) & (US$ Million)
Figure 13. Global Cystic Fibrosis Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 14. Global Cystic Fibrosis Drugs Revenue Market Share by Region: 2025 Versus 2032
Figure 15. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2021-2032)
Figure 16. Global Cystic Fibrosis Drugs Sales (2021-2032) & (K Units)
Figure 17. Global Cystic Fibrosis Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Figure 18. Global Cystic Fibrosis Drugs Sales Market Share by Region (2021-2032)
Figure 19. US & Canada & Mexico Cystic Fibrosis Drugs Sales YoY (2021-2032) & (K Units)
Figure 20. Europe Cystic Fibrosis Drugs Sales YoY (2021-2032) & (K Units)
Figure 21. China Cystic Fibrosis Drugs Sales YoY (2021-2032) & (K Units)
Figure 22. Asia (Excluding China) Cystic Fibrosis Drugs Sales YoY (2021-2032) & (K Units)
Figure 23. South America, Middle East and Africa Cystic Fibrosis Drugs Sales YoY (2021-2032) & (K Units)
Figure 24. Global Cystic Fibrosis Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
Figure 25. Global Cystic Fibrosis Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 27. Global Cystic Fibrosis Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 28. Global Cystic Fibrosis Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032
Figure 29. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2021-2032)
Figure 30. Global Cystic Fibrosis Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 31. Global Cystic Fibrosis Drugs Sales Market Share by Type 2021 VS 2025 VS 2032
Figure 32. Global Cystic Fibrosis Drugs Sales Market Share by Type (2021-2032)
Figure 33. Global Cystic Fibrosis Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 34. Global Cystic Fibrosis Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032
Figure 35. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2021-2032)
Figure 36. Global Cystic Fibrosis Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 37. Global Cystic Fibrosis Drugs Sales Market Share by Application 2021 VS 2025 VS 2032
Figure 38. Global Cystic Fibrosis Drugs Sales Market Share by Application (2021-2032)
Figure 39. North America Cystic Fibrosis Drugs Revenue Share by Type (2021-2032)
Figure 40. North America Cystic Fibrosis Drugs Sales Share by Type (2021-2032)
Figure 41. North America Cystic Fibrosis Drugs Revenue Share by Application (2021-2032)
Figure 42. North America Cystic Fibrosis Drugs Sales Share by Application (2021-2032)
Figure 43. North America Cystic Fibrosis Drugs Revenue Share by Country (2021-2032)
Figure 44. North America Cystic Fibrosis Drugs Sales Share by Country (2021-2032)
Figure 45. Europe Cystic Fibrosis Drugs Revenue Share by Type (2021-2032)
Figure 46. Europe Cystic Fibrosis Drugs Sales Share by Type (2021-2032)
Figure 47. Europe Cystic Fibrosis Drugs Revenue Share by Application (2021-2032)
Figure 48. Europe Cystic Fibrosis Drugs Sales Share by Application (2021-2032)
Figure 49. Europe Cystic Fibrosis Drugs Revenue Share by Country (2021-2032)
Figure 50. Europe Cystic Fibrosis Drugs Sales Share by Country (2021-2032)
Figure 51. China Cystic Fibrosis Drugs Revenue Share by Type (2021-2032)
Figure 52. China Cystic Fibrosis Drugs Sales Share by Type (2021-2032)
Figure 53. China Cystic Fibrosis Drugs Revenue Share by Application (2021-2032)
Figure 54. China Cystic Fibrosis Drugs Sales Share by Application (2021-2032)
Figure 55. Asia Cystic Fibrosis Drugs Revenue Share by Type (2021-2032)
Figure 56. Asia Cystic Fibrosis Drugs Sales Share by Type (2021-2032)
Figure 57. Asia Cystic Fibrosis Drugs Revenue Share by Application (2021-2032)
Figure 58. Asia Cystic Fibrosis Drugs Sales Share by Application (2021-2032)
Figure 59. Asia Cystic Fibrosis Drugs Revenue Share by Country (2021-2032)
Figure 60. Asia Cystic Fibrosis Drugs Sales Share by Country (2021-2032)
Figure 61. SAMEA Cystic Fibrosis Drugs Revenue Share by Type (2021-2032)
Figure 62. SAMEA Cystic Fibrosis Drugs Sales Share by Type (2021-2032)
Figure 63. SAMEA Cystic Fibrosis Drugs Revenue Share by Application (2021-2032)
Figure 64. SAMEA Cystic Fibrosis Drugs Sales Share by Application (2021-2032)
Figure 65. SAMEA Cystic Fibrosis Drugs Revenue Share by Country (2021-2032)
Figure 66. SAMEA Cystic Fibrosis Drugs Sales Share by Country (2021-2032)
Figure 67. Cystic Fibrosis Drugs Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Cystic Fibrosis Drugs Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
Scope & coverage.
Types
- Oral Cystic Fibrosis Drugs
- Injection Cystic Fibrosis Drugs
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Abbott
- Johnson & Johnson
- Novartis
- Vertex Pharmaceuticals
- Venus Remedies
- United Medical
- PTC Therapeutics
- Proteostasis Therapeutics
- Pharmaxis
- PharmaSwiss
- Novo Nordisk
- Neovii Biotech
- Merck Sharp & Dohme
- Insmed
- Gilead Sciences
- Genzyme
- F. Hoffmann-La Roche
- Corbus Pharmaceuticals
- Chiesi Farmaceutici
- Boehringer Ingelheim
- Arcturus Therapeutics
- Anthera Pharmaceuticals
- Actavis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cystic Fibrosis Drugs Market by Type
- 1.2.1 Global Cystic Fibrosis Drugs Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Oral Cystic Fibrosis Drugs
- 1.2.3 Injection Cystic Fibrosis Drugs
- 1.3 Cystic Fibrosis Drugs Market by Application
- 1.3.1 Global Cystic Fibrosis Drugs Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cystic Fibrosis Drugs Market Dynamics
- 2.1 Cystic Fibrosis Drugs Industry Trends
- 2.2 Cystic Fibrosis Drugs Industry Drivers
- 2.3 Cystic Fibrosis Drugs Industry Opportunities and Challenges
- 2.4 Cystic Fibrosis Drugs Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Cystic Fibrosis Drugs Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Cystic Fibrosis Drugs Revenue by Region
- 3.2.1 Global Cystic Fibrosis Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cystic Fibrosis Drugs Revenue by Region (2021-2026)
- 3.2.3 Global Cystic Fibrosis Drugs Revenue by Region (2027-2032)
- 3.2.4 Global Cystic Fibrosis Drugs Revenue Market Share by Region (2021-2032)
- 3.3 Global Cystic Fibrosis Drugs Sales Estimates and Forecasts 2021-2032
- 3.4 Global Cystic Fibrosis Drugs Sales by Region
- 3.4.1 Global Cystic Fibrosis Drugs Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Cystic Fibrosis Drugs Sales by Region (2021-2026)
- 3.4.3 Global Cystic Fibrosis Drugs Sales by Region (2027-2032)
- 3.4.4 Global Cystic Fibrosis Drugs Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Cystic Fibrosis Drugs Revenue by Manufacturers
- 4.1.1 Global Cystic Fibrosis Drugs Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Cystic Fibrosis Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cystic Fibrosis Drugs Sales by Manufacturers
- 4.2.1 Global Cystic Fibrosis Drugs Sales by Manufacturers (2021-2026)
- 4.2.2 Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Cystic Fibrosis Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Cystic Fibrosis Drugs Sales Price by Manufacturers (2021-2026)
- 4.4 Global Cystic Fibrosis Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Cystic Fibrosis Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Cystic Fibrosis Drugs Manufacturers, Product Type & Application
- 4.7 Global Cystic Fibrosis Drugs Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Cystic Fibrosis Drugs Market CR5 and HHI
- 4.8.2 2025 Cystic Fibrosis Drugs Tier 1, Tier 2, and Tier 3
5 Cystic Fibrosis Drugs Market by Type
- 5.1 Global Cystic Fibrosis Drugs Revenue by Type
- 5.1.1 Global Cystic Fibrosis Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Cystic Fibrosis Drugs Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2021-2032)
- 5.2 Global Cystic Fibrosis Drugs Sales by Type
- 5.2.1 Global Cystic Fibrosis Drugs Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Cystic Fibrosis Drugs Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Cystic Fibrosis Drugs Sales Market Share by Type (2021-2032)
- 5.3 Global Cystic Fibrosis Drugs Price by Type
6 Cystic Fibrosis Drugs Market by Application
- 6.1 Global Cystic Fibrosis Drugs Revenue by Application
- 6.1.1 Global Cystic Fibrosis Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Cystic Fibrosis Drugs Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2021-2032)
- 6.2 Global Cystic Fibrosis Drugs Sales by Application
- 6.2.1 Global Cystic Fibrosis Drugs Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Cystic Fibrosis Drugs Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Cystic Fibrosis Drugs Sales Market Share by Application (2021-2032)
- 6.3 Global Cystic Fibrosis Drugs Price by Application
7 Company Profiles
- 7.1 Abbott
- 7.1.1 Abbott Company Information
- 7.1.2 Abbott Business Overview
- 7.1.3 Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Abbott Cystic Fibrosis Drugs Product Portfolio
- 7.1.5 Abbott Recent Developments
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Company Information
- 7.2.2 Johnson & Johnson Business Overview
- 7.2.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
- 7.2.5 Johnson & Johnson Recent Developments
- 7.3 Novartis
- 7.3.1 Novartis Company Information
- 7.3.2 Novartis Business Overview
- 7.3.3 Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Novartis Cystic Fibrosis Drugs Product Portfolio
- 7.3.5 Novartis Recent Developments
- 7.4 Vertex Pharmaceuticals
- 7.4.1 Vertex Pharmaceuticals Company Information
- 7.4.2 Vertex Pharmaceuticals Business Overview
- 7.4.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 7.4.5 Vertex Pharmaceuticals Recent Developments
- 7.5 Venus Remedies
- 7.5.1 Venus Remedies Company Information
- 7.5.2 Venus Remedies Business Overview
- 7.5.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
- 7.5.5 Venus Remedies Recent Developments
- 7.6 United Medical
- 7.6.1 United Medical Company Information
- 7.6.2 United Medical Business Overview
- 7.6.3 United Medical Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 United Medical Cystic Fibrosis Drugs Product Portfolio
- 7.6.5 United Medical Recent Developments
- 7.7 PTC Therapeutics
- 7.7.1 PTC Therapeutics Company Information
- 7.7.2 PTC Therapeutics Business Overview
- 7.7.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 7.7.5 PTC Therapeutics Recent Developments
- 7.8 Proteostasis Therapeutics
- 7.8.1 Proteostasis Therapeutics Company Information
- 7.8.2 Proteostasis Therapeutics Business Overview
- 7.8.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 7.8.5 Proteostasis Therapeutics Recent Developments
- 7.9 Pharmaxis
- 7.9.1 Pharmaxis Company Information
- 7.9.2 Pharmaxis Business Overview
- 7.9.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
- 7.9.5 Pharmaxis Recent Developments
- 7.10 PharmaSwiss
- 7.10.1 PharmaSwiss Company Information
- 7.10.2 PharmaSwiss Business Overview
- 7.10.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
- 7.10.5 PharmaSwiss Recent Developments
- 7.11 Novo Nordisk
- 7.11.1 Novo Nordisk Company Information
- 7.11.2 Novo Nordisk Business Overview
- 7.11.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
- 7.11.5 Novo Nordisk Recent Developments
- 7.12 Neovii Biotech
- 7.12.1 Neovii Biotech Company Information
- 7.12.2 Neovii Biotech Business Overview
- 7.12.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
- 7.12.5 Neovii Biotech Recent Developments
- 7.13 Merck Sharp & Dohme
- 7.13.1 Merck Sharp & Dohme Company Information
- 7.13.2 Merck Sharp & Dohme Business Overview
- 7.13.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
- 7.13.5 Merck Sharp & Dohme Recent Developments
- 7.14 Insmed
- 7.14.1 Insmed Company Information
- 7.14.2 Insmed Business Overview
- 7.14.3 Insmed Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Insmed Cystic Fibrosis Drugs Product Portfolio
- 7.14.5 Insmed Recent Developments
- 7.15 Gilead Sciences
- 7.15.1 Gilead Sciences Company Information
- 7.15.2 Gilead Sciences Business Overview
- 7.15.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
- 7.15.5 Gilead Sciences Recent Developments
- 7.16 Genzyme
- 7.16.1 Genzyme Company Information
- 7.16.2 Genzyme Business Overview
- 7.16.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
- 7.16.5 Genzyme Recent Developments
- 7.17 F. Hoffmann-La Roche
- 7.17.1 F. Hoffmann-La Roche Company Information
- 7.17.2 F. Hoffmann-La Roche Business Overview
- 7.17.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.17.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
- 7.17.5 F. Hoffmann-La Roche Recent Developments
- 7.18 Corbus Pharmaceuticals
- 7.18.1 Corbus Pharmaceuticals Company Information
- 7.18.2 Corbus Pharmaceuticals Business Overview
- 7.18.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.18.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 7.18.5 Corbus Pharmaceuticals Recent Developments
- 7.19 Chiesi Farmaceutici
- 7.19.1 Chiesi Farmaceutici Company Information
- 7.19.2 Chiesi Farmaceutici Business Overview
- 7.19.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.19.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
- 7.19.5 Chiesi Farmaceutici Recent Developments
- 7.20 Boehringer Ingelheim
- 7.20.1 Boehringer Ingelheim Company Information
- 7.20.2 Boehringer Ingelheim Business Overview
- 7.20.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.20.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
- 7.20.5 Boehringer Ingelheim Recent Developments
- 7.21 Arcturus Therapeutics
- 7.21.1 Arcturus Therapeutics Company Information
- 7.21.2 Arcturus Therapeutics Business Overview
- 7.21.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.21.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 7.21.5 Arcturus Therapeutics Recent Developments
- 7.22 Anthera Pharmaceuticals
- 7.22.1 Anthera Pharmaceuticals Company Information
- 7.22.2 Anthera Pharmaceuticals Business Overview
- 7.22.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.22.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 7.22.5 Anthera Pharmaceuticals Recent Developments
- 7.23 Actavis
- 7.23.1 Actavis Company Information
- 7.23.2 Actavis Business Overview
- 7.23.3 Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.23.4 Actavis Cystic Fibrosis Drugs Product Portfolio
- 7.23.5 Actavis Recent Developments
8 North America
- 8.1 North America Cystic Fibrosis Drugs Market Size by Type
- 8.1.1 North America Cystic Fibrosis Drugs Revenue by Type (2021-2032)
- 8.1.2 North America Cystic Fibrosis Drugs Sales by Type (2021-2032)
- 8.1.3 North America Cystic Fibrosis Drugs Price by Type (2021-2032)
- 8.2 North America Cystic Fibrosis Drugs Market Size by Application
- 8.2.1 North America Cystic Fibrosis Drugs Revenue by Application (2021-2032)
- 8.2.2 North America Cystic Fibrosis Drugs Sales by Application (2021-2032)
- 8.2.3 North America Cystic Fibrosis Drugs Price by Application (2021-2032)
- 8.3 North America Cystic Fibrosis Drugs Market Size by Country
- 8.3.1 North America Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Cystic Fibrosis Drugs Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Cystic Fibrosis Drugs Market Size by Type
- 9.1.1 Europe Cystic Fibrosis Drugs Revenue by Type (2021-2032)
- 9.1.2 Europe Cystic Fibrosis Drugs Sales by Type (2021-2032)
- 9.1.3 Europe Cystic Fibrosis Drugs Price by Type (2021-2032)
- 9.2 Europe Cystic Fibrosis Drugs Market Size by Application
- 9.2.1 Europe Cystic Fibrosis Drugs Revenue by Application (2021-2032)
- 9.2.2 Europe Cystic Fibrosis Drugs Sales by Application (2021-2032)
- 9.2.3 Europe Cystic Fibrosis Drugs Price by Application (2021-2032)
- 9.3 Europe Cystic Fibrosis Drugs Market Size by Country
- 9.3.1 Europe Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Cystic Fibrosis Drugs Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Cystic Fibrosis Drugs Market Size by Type
- 10.1.1 China Cystic Fibrosis Drugs Revenue by Type (2021-2032)
- 10.1.2 China Cystic Fibrosis Drugs Sales by Type (2021-2032)
- 10.1.3 China Cystic Fibrosis Drugs Price by Type (2021-2032)
- 10.2 China Cystic Fibrosis Drugs Market Size by Application
- 10.2.1 China Cystic Fibrosis Drugs Revenue by Application (2021-2032)
- 10.2.2 China Cystic Fibrosis Drugs Sales by Application (2021-2032)
- 10.2.3 China Cystic Fibrosis Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cystic Fibrosis Drugs Market Size by Type
- 11.1.1 Asia Cystic Fibrosis Drugs Revenue by Type (2021-2032)
- 11.1.2 Asia Cystic Fibrosis Drugs Sales by Type (2021-2032)
- 11.1.3 Asia Cystic Fibrosis Drugs Price by Type (2021-2032)
- 11.2 Asia Cystic Fibrosis Drugs Market Size by Application
- 11.2.1 Asia Cystic Fibrosis Drugs Revenue by Application (2021-2032)
- 11.2.2 Asia Cystic Fibrosis Drugs Sales by Application (2021-2032)
- 11.2.3 Asia Cystic Fibrosis Drugs Price by Application (2021-2032)
- 11.3 Asia Cystic Fibrosis Drugs Market Size by Country
- 11.3.1 Asia Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Cystic Fibrosis Drugs Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cystic Fibrosis Drugs Market Size by Type
- 12.1.1 SAMEA Cystic Fibrosis Drugs Revenue by Type (2021-2032)
- 12.1.2 SAMEA Cystic Fibrosis Drugs Sales by Type (2021-2032)
- 12.1.3 SAMEA Cystic Fibrosis Drugs Price by Type (2021-2032)
- 12.2 SAMEA Cystic Fibrosis Drugs Market Size by Application
- 12.2.1 SAMEA Cystic Fibrosis Drugs Revenue by Application (2021-2032)
- 12.2.2 SAMEA Cystic Fibrosis Drugs Sales by Application (2021-2032)
- 12.2.3 SAMEA Cystic Fibrosis Drugs Price by Application (2021-2032)
- 12.3 SAMEA Cystic Fibrosis Drugs Market Size by Country
- 12.3.1 SAMEA Cystic Fibrosis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Cystic Fibrosis Drugs Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Cystic Fibrosis Drugs Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Cystic Fibrosis Drugs Value Chain Analysis
- 13.1.1 Cystic Fibrosis Drugs Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Cystic Fibrosis Drugs Production Mode & Process
- 13.2 Cystic Fibrosis Drugs Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Cystic Fibrosis Drugs Distributors
- 13.2.3 Cystic Fibrosis Drugs Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst